LEADER 00793cam0-22003131i-450- 001 990007294280403321 005 20050202150040.0 010 $a2-264-00388-X 035 $a000729428 035 $aFED01000729428 035 $a(Aleph)000729428FED01 035 $a000729428 100 $a20021021d1981----km-y0itay50------ba 101 0 $afre 102 $aFR 105 $ay-------001yy 200 1 $aKeynes$fpar Michel Herland 210 $aParis$cUnion Générale d'édition$d1981 215 $a371 p.$d20 cm 700 1$aHerland,$bMichel$0260710 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990007294280403321 952 $aIG XV G1 10$fDTE 952 $aXV G[1] 10$b115490$fFGBC 959 $aDTE 959 $aFGBC 996 $aKeynes$9696392 997 $aUNINA LEADER 00943nam0-2200313---450 001 990009292670403321 005 20171026132123.0 035 $a000929267 035 $aFED01000929267 035 $a(Aleph)000929267FED01 035 $a000929267 100 $a20101207d1916----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $ay-------001yy 200 1 $aDei sieri, vaccini e prodotti opoterapici I.S.M.$fLuigi Viganò, Alberto Orsi, Serafino Belfanti 210 $aMilano$cIstituto sieroterapico milanese$d1916 215 $aVI, 355 p.$d16 cm 610 0 $aVaccini 700 1$aViganò,$bLuigi$0509538 701 1$aOrsi,$bAlberto$0509539 701 1$aBelfanti,$bSerafino$0509540 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990009292670403321 952 $a90 CCH MED. INF. 3$b838$fFMEBC 959 $aFMEBC 996 $aDei sieri, vaccini e prodotti opoterapici I.S.M$9770255 997 $aUNINA LEADER 00892nam a22002651i 4500 001 991001660489707536 005 20031201124744.0 008 040407s1979 it a||||||||||||||||ita 035 $ab12804290-39ule_inst 035 $aARCHE-078392$9ExL 040 $aDip.to Scienze Storiche$bita$cA.t.i. Arché s.c.r.l. Pandora Sicilia s.r.l. 082 04$a551.5 100 1 $aNangeroni, Giuseppe$034020 245 13$aIl clima /$cGiuseppe Nangeroni 250 $a5. rist. 260 $aTorino :$bLoescher,$c1979 300 $a65 p. :$bill. ;$c24 cm 440 3$aLa ricerca ;$v24 650 4$aClima 907 $a.b12804290$b02-04-14$c16-04-04 912 $a991001660489707536 945 $aLE009 GEOG.10.5-113$g1$i2009000176911$lle009$o-$pE0.00$q-$rl$s- $t0$u1$v0$w1$x0$y.i13351771$z16-04-04 996 $aClima$9294311 997 $aUNISALENTO 998 $ale009$b16-04-04$cm$da $e-$fita$git $h3$i1